Intalere Chooses TraceLink to Offer DSCSA Compliance Solutions to Over 90,000 Members
TraceLink Now Has Access to Over 80% of Entire U.S. Hospital Market Through its GPO Partnerships
TraceLink, the World’s Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced a national group purchasing contract with Intalere, an industry leader in delivering optimal cost, quality and clinical outcomes for its members. Under this agreement, TraceLink’s market-leading Product Track solution will be offered at pre-negotiated contract terms and pricing for approximately 90,000 healthcare providers within the Intalere member network, providing them with an affordable path to comply with the U.S. Drug Supply Chain Security Act (DSCSA).
This partnership further validates TraceLink’s position as the leading solution provider for DSCSA compliance and adds to TraceLink’s growing network of group purchasing organization (GPO) alliances, which now covers more than 80 percent of the entire U.S. hospital market.
With the TraceLink Product Track solution, Intalere members will also join the TraceLink network of more than 240,000 global healthcare entities working together to secure the pharmaceutical supply
“We are excited to partner with
Learn more about how TraceLink can help protect pharmacy operations, easily help them meet DSCSA requirements and enable a direct connection with over 1,000 suppliers, ranging from the “Big Three” wholesale distributors and the largest pharmaceutical manufacturers.